Materialise has delivered evidence of both the clinical and economic benefits of the use of its aMace hip implants compared to the best alternative currently – milled titanium three-flange implants – and is proud to have obtained reimbursement from the Belgian social security organization, RIZIV. This has been possible thanks to collaboration and support from a number of hospitals. As the amount of patients that require a complex hip implant (Paprosky type 3B classified) is very low (less than 10 in 1 million patients according to the definition), we consider this a unique accomplishment in our sector. The low failure rate of those implants makes them even more economically interesting for the Belgian social security system. We acknowledge that for multiple types of 3D-printed implants the evidence gathered so far is not yet complete and more work needs to be done.
At Materialise we remain committed to delivering positive proof that 3D-printed implants are helping a large amount of patients that could not be helped before. We help them in a secure, quality-controlled environment, with meaningful applications that create value for the patient and healthcare systems around the world.
Discover when and how orthopedic surgeons integrate patient-specific implants in their daily practice. Watch the recording of the THINK Webinar series: Benefits of 3D Printing in Orthopedics.